Angela Jo Bymaster, MD
Family Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 8 carriers
- Office
- 1
Offices
1 location
Plans that list them
22 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bymaster’s office at (408) 583-6338 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A101603 · Current
Licensed to practise in California · since 2007 · expires 2027-08-31 · University of Iowa College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$0 in 2022
Medicaid paid $0 for 44 billed services this clinician did in 2022, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 44 | $0 |
| 2022 | 44 | 1 | 16 | $0 |
| 2020 | 1,437 | 6 | 195 | $56,205 |
| 2019 | 5,268 | 11 | 203 | $207,952 |
| 2018 | 6,300 | 20 | 216 | $258,710 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 561 | $53,093 |
| Short return visit (20+ min) | 691 | $2,267 |
| Return visit (30+ min) | 74 | $511 |
| Long return visit (40+ min) | 22 | $313 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 45 | $16 |
| HEMOGLOBIN | 44 | $4 |
2019
| Clinic visit/encounter, all-inclusive | 2,167 | $190,878 |
| Short return visit (20+ min) | 1,840 | $11,492 |
| Return visit (30+ min) | 343 | $4,040 |
| Long return visit (40+ min) | 78 | $719 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 78 | $345 |
| Screening test, pure tone, air only | 142 | $207 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 192 | $148 |
| HEMOGLOBIN | 304 | $76 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 15 | $39 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 46 | $8 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 63 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 2,721 | $231,727 |
| Short return visit (20+ min) | 1,260 | $13,685 |
| Return visit (30+ min) | 491 | $6,542 |
| New patient visit (30+ min) | 103 | $2,395 |
| Long return visit (40+ min) | 102 | $1,742 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 177 | $396 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 78 | $394 |
| Short return visit | 22 | $371 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 439 | $353 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 36 | $295 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 29 | $258 |
| OFF/OP EST MAY X REQ PHY/QHP | 66 | $206 |
Drugs they prescribed that Part D paid
$26,677
Pharmacies billed $26,677 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 381) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
316 generic and fewer than 11 brand-name prescriptions · $26,677 in drug cost · 23 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Qvar Redihaler | 15 | $4,415 | $294 |
| Buprenorphine-Naloxone | 13 | $1,165 | $90 |
| Ventolin Hfa | 13 | $725 | $56 |
| Armodafinil | 12 | $430 | $36 |
| Fluoxetine | 18 | $284 | $16 |
See all 11 drugs
| Qvar Redihaler | 15 | $4,415 | $294 |
| Buprenorphine-Naloxone | 13 | $1,165 | $90 |
| Ventolin Hfa | 13 | $725 | $56 |
| Armodafinil | 12 | $430 | $36 |
| Fluoxetine | 18 | $284 | $16 |
| Tamsulosin | 11 | $207 | $19 |
| Losartan | 20 | $148 | $7 |
| Amlodipine Besylate | 16 | $106 | $7 |
| Levothyroxine | 19 | $94 | $5 |
| Donepezil | 14 | $87 | $6 |
| Furosemide | 13 | $59 | $5 |
Year by year
| 2024 | 381 | 29 | 3% (13) | None | $26,677 |
| 2023 | 226 | 28 | None | None | $17,840 |
| 2022 | 139 | 18 | 0% (0) | None | $5,960 |
| 2021 | 35 | None | None | 46% | $7,525 |
| 2020 | 142 | 23 | None | None | $11,111 |
| 2019 | 410 | 26 | 7% (29) | None | $25,346 |
| 2018 | 283 | 20 | None | 13% | $12,047 |
| 2017 | 182 | 12 | None | 14% | $8,309 |
| 2016 | 138 | 16 | None | None | $1,800 |
| 2015 | 355 | 53 | 16% (56) | 28% | $18,602 |
| 2014 | 369 | 62 | 18% (66) | None | $17,468 |
| 2013 | 373 | 49 | 18% (66) | None | $11,611 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Breo Ellipta | 12 | $5,160 | $430 |
| Tamsulosin | 11 | $335 | $30 |
| Fluoxetine | 16 | $316 | $20 |
| Losartan | 13 | $198 | $15 |
| Donepezil | 15 | $98 | $7 |
2021: 1 drug
| Repatha Sureclick | 12 | $5,994 | $499 |
2019: 13 drugs
| Zubsolv | 13 | $6,789 | $522 |
| Lantus Solostar | 13 | $5,301 | $408 |
| Hydrocodone-Acetaminophen | 18 | $316 | $18 |
| Clonidine | 22 | $213 | $10 |
| Gabapentin | 20 | $198 | $10 |
| Lisinopril | 22 | $173 | $8 |
| Amlodipine Besylate | 18 | $160 | $9 |
| Simvastatin | 16 | $135 | $8 |
| Metformin | 17 | $104 | $6 |
| Atorvastatin | 12 | $83 | $7 |
| Glipizide | 14 | $73 | $5 |
| Omeprazole | 11 | $64 | $6 |
| Clonazepam | 11 | $32 | $3 |
2018: 6 drugs
| Venlafaxine Hcl Er | 26 | $544 | $21 |
| Clonidine | 21 | $113 | $5 |
| Amlodipine Besylate | 19 | $96 | $5 |
| Gabapentin | 12 | $78 | $6 |
| Trazodone | 13 | $72 | $6 |
| Ranitidine | 11 | $72 | $7 |
2017: 8 drugs
| Spiriva | 11 | $4,324 | $393 |
| Doxazosin Mesylate | 12 | $585 | $49 |
| Venlafaxine Hcl Er | 26 | $585 | $22 |
| Metformin | 26 | $194 | $7 |
| Simvastatin | 15 | $155 | $10 |
| Amlodipine Besylate | 11 | $68 | $6 |
| Clonidine | 12 | $65 | $5 |
| Trazodone | 11 | $55 | $5 |
2016: 5 drugs
| Venlafaxine Hcl Er | 11 | $385 | $35 |
| Metformin | 25 | $208 | $8 |
| Sertraline | 11 | $69 | $6 |
| Glipizide | 12 | $69 | $6 |
| Simvastatin | 14 | $68 | $5 |
2015: 8 drugs
| Suboxone | 17 | $4,546 | $267 |
| Oxycodone-Acetaminophen | 20 | $410 | $21 |
| Gabapentin | 17 | $368 | $22 |
| Bupropion Xl | 11 | $270 | $25 |
| Methadone | 20 | $203 | $10 |
| Risperidone | 14 | $109 | $8 |
| Naproxen | 13 | $100 | $8 |
| Trazodone | 14 | $77 | $6 |
2014: 5 drugs
| Gabapentin | 19 | $674 | $35 |
| Oxycodone-Acetaminophen | 20 | $287 | $14 |
| Methadone | 23 | $261 | $11 |
| Tamsulosin | 12 | $258 | $22 |
| Omeprazole | 15 | $177 | $12 |
2013: 12 drugs
| Gabapentin | 11 | $229 | $21 |
| Methadone | 27 | $200 | $7 |
| Pravastatin | 14 | $159 | $11 |
| Carisoprodol | 11 | $152 | $14 |
| Fosinopril | 18 | $124 | $7 |
| Oxycodone-Acetaminophen | 15 | $110 | $7 |
| Hydrocodone-Acetaminophen | 15 | $106 | $7 |
| Amlodipine Besylate | 12 | $90 | $8 |
| Citalopram Hbr | 13 | $79 | $6 |
| Hydrochlorothiazide | 19 | $71 | $4 |
| Lorazepam | 12 | $57 | $5 |
| Trazodone | 11 | $51 | $5 |
Money from drug and device companies
$45 in 2025
| 2025 | 1 | 2 | None | $45 |
| 2024 | 2 | 3 | None | $48 |
| 2023 | 2 | 2 | None | $36 |
| 2022 | 1 | 2 | None | $135 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $45 | 2 payments
|
See all 2 published payments
| Novo Nordisk | Meals · 2025-08-26 | Wegovy | $18 |
| Novo Nordisk | Meals · 2025-07-15 | Wegovy | $27 |
See earlier years (2024, 2023, 2022)
2024: $48
| Novo Nordisk | Wegovy | $30 | 2 payments
|
| Indivior | Sublocade | $19 | 1 payment
|
2023: $36
| Organon | Nexplanon | $22 | 1 payment
|
| Novo Nordisk | Saxenda | $14 | 1 payment
|
2022: $135
| Novo Nordisk | Saxenda | $135 | 2 payments
|
Professional record
- NPI
- 1437392263
- Licence
- CA A101603California A101603: Current · expires 2027-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 448 Goodyear St, San Jose, CA, 95110
- NPI first listed
- 2009-04-09
- NPI last updated
- 2020-05-21
- NPI record certified
- 2020-05-21
This is when the NPI record was last certified, not a medical board exam.